Everything below concerns Hydrolyzed collagen. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Collagen peptides are short chains of amino acids produced by hydrolyzing collagen from animal tissues. The raw material commonly comes from bovine hide, porcine skin, fish skin, or poultry cartilage. Hydrolysis breaks native collagen's triple helix into smaller fragments and increases water solubility relative to intact collagen. The resulting mixture contains peptides of varying lengths rather than a single molecular species; commercial samples are often described by average molecular weight or by a size range. This broad composition affects functional properties such as gelation, foaming, and mouthfeel.
Enzymatic, alkaline, or acid treatments can cleave collagen into peptides. Enzymatic hydrolysis with proteases is common because it allows control over temperature, pH, and reaction time, while the choice of enzyme and raw material influences the peptide profile and amino acid composition. Glycine, proline, and hydroxyproline are abundant in collagen peptides, whereas tryptophan is typically low or absent. Hydroxyproline serves as a characteristic marker for collagen-derived material. Processing conditions also affect color, odor, and taste, which matter for food and supplement applications.
Quality control for collagen peptide ingredients combines identity, purity, and composition tests. Molecular weight distribution is a primary specification because hydrolysis determines peptide chain length, which influences solubility and flow properties. Amino acid analysis confirms the expected high levels of glycine, proline, and hydroxyproline. Moisture, ash, pH, and microbial limits are checked to ensure consistent handling and shelf life. No single assay captures every relevant property, so manufacturers typically use a panel of methods.
Species origin is not always easy to confirm in finished hydrolysates because hydrolysis fragments DNA as well as protein. Polymerase chain reaction tests targeting species-specific DNA may fail when the template is too short. Amino acid profiles, stable isotope ratios, and trace element patterns can offer indirect clues, but they are not definitive on their own. Adulteration with cheaper nitrogen-rich ingredients is a documented concern in some protein markets. Buyers often rely on supplier audits, certificates of analysis, and third-party testing to verify source and purity.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow powder | Color can vary with raw material and processing |
| Solubility | Soluble in water; insoluble in ethanol and oils | Solubility increases with degree of hydrolysis |
| Typical molecular weight | 2–10 kDa | Commercial grades may range from 1–20 kDa |
| Characteristic amino acid | Hydroxyproline | Used as a marker for collagen-derived peptides |
| Common synonyms | Hydrolyzed collagen; collagen hydrolysate | Labels vary by region and intended use |
Collagen peptides are short-chain proteins produced by hydrolyzing native collagen, the main structural protein in skin, bone, tendon, and cartilage. The hydrolysis step breaks the triple-helical structure and cleaves longer chains into smaller fragments. The resulting material is water-soluble and typically has an average molecular weight in the low kilodalton range. Commercial ingredients are often described as hydrolyzed collagen or collagen hydrolysate. Amino acid composition remains rich in glycine, proline, and hydroxyproline, though the ordered helical arrangement is largely lost.
Raw collagen for peptide production comes from bovine hide, porcine skin, fish skin and scales, and sometimes poultry cartilage. The material is cleaned, extracted, and treated with acid, alkali, or enzymes to break peptide bonds. Enzymatic hydrolysis using proteases allows better control of fragment size than purely chemical methods. After hydrolysis, the liquid is filtered, concentrated, and dried into a powder. Source and processing conditions influence color, odor, molecular weight distribution, and amino acid profile.
Collagen peptides are short chains of amino acids produced by hydrolyzing collagen extracted from animal connective tissues. The hydrolysis process breaks the native triple helix into smaller fragments, typically through enzymatic or chemical treatment. Sources include bovine hide, porcine skin, fish scales, and poultry cartilage; the resulting material is water-soluble and can be dried into a powder. Commercial production often uses controlled temperature and pH to achieve a consistent average molecular mass. The degree of hydrolysis influences the peptide size distribution and functional properties.
The amino acid profile of collagen peptides is distinctive, with glycine, proline, and hydroxyproline together accounting for a large fraction of residues. Glycine appears at nearly every third position in the original collagen sequence, a pattern partly retained in shorter peptides. Hydroxyproline is formed by post-translational modification of proline and serves as a marker for collagen-derived material. Unlike many proteins, collagen peptides contain little or no tryptophan and low levels of cysteine.
==== MeSH D12.776.467.374.400 – growth substances ==== MeSH D12.776.467.374.400.442 – hematopoietic cell growth factors MeSH D12.776.467.374.400.442.240 – colony-stimulating factors MeSH D12.776.467.374.400.442.240.075 – colony-stimulating factors, recombinant MeSH D12.776.467.374.400.442.240.075.350 – granulocyte colony stimulating factor, recombinant MeSH D12.776.467.374.400.442.240.075.350.275 – filgrastim MeSH D12.776.467.374.400.442.240.075.375 – granulocyte macrophage colony-stimulating factors, recombinant MeSH D12.776.467.374.400.442.240.150 – erythropoietin MeSH D12.776.467.374.400.442.240.150.250 – erythropoietin, recombinant MeSH D12.776.467.374.400.442.240.150.250.250 – epoetin alfa MeSH D12.776.467.374.400.442.240.350 – granulocyte colony-stimulating factor MeSH D12.776.467.374.400.442.240.350.375 – granulocyte colony stimulating factor, recombinant MeSH D12.776.467.374.400.442.240.350.375.275 – filgrastim MeSH D12.776.467.374.400.442.240.375 – granulocyte-macrophage colony-stimulating factor MeSH D12.776.467.374.400.442.240.375.275 – granulocyte macrophage colony-stimulating factors, recombinant MeSH D12.776.467.374.400.442.240.400 – interleukin-3 MeSH D12.776.467.374.400.442.240.500 – macrophage colony-stimulating factor MeSH D12.776.467.374.400.442.240.750 – thrombopoietin MeSH D12.776.467.374.400.442.800 – stem cell factor MeSH D12.776.467.374.400.505 – interleukins MeSH D12.776.467.374.400.505.501 – interleukin-1 MeSH D12.776.467.374.400.505.502 – interleukin-2 MeSH D12.776.467.374.400.505.503 – interleukin-3 MeSH D12.776.467.374.400.505.504 – interleukin-4 MeSH D12.776.467.374.400.505.505 – interleukin-5 MeSH D12.776.467.374.400.505.506 – interleukin-6 MeSH D12.776.467.374.400.505.507 – interleukin-7 MeSH D12.776.467.374.400.505.508 – interleukin-8 MeSH D12.776.467.374.400.505.509 – interleukin-9 MeSH D12.776.467.374.400.505.510 – interleukin-10 MeSH D12.776.467.374.400.505.511 – interleukin-11 MeSH D12.776.467.374.400.505.512 – interleukin-12 MeSH D12.776.467.374.400.505.513 – interleukin-13 MeSH D12.776.467.374.400.505.514 – interleukin-14 MeSH D12.776.467.374.400.505.515 – interleukin-15 MeSH D12.776.467.374.400.505.516 – interleukin-16 MeSH D12.776.467.374.400.505.517 – interleukin-17 MeSH D12.776.467.374.400.505.518 – interleukin-18 MeSH D12.776.467.374.400.800 – transforming growth factor beta
Unfortunately, therapies which lower testosterone levels, such as orchiectomy or GnRH analogue administration, also have significant side effects. Compared to these therapies, treatment with antiandrogens exhibits "fewer hot flashes, less of an effect on libido, less muscle wasting, fewer personality changes, and less bone loss." However, antiandrogen therapy alone is less effective than surgery. Nevertheless, given the advanced age of many with prostate cancer, as well as other features, many men may choose antiandrogen therapy alone for a better quality of life. Flutamide has been found to be similarly effective in the treatment of prostate cancer to bicalutamide, although indications of inferior efficacy, including greater compensatory increases in testosterone levels and greater reductions in PSA levels with bicalutamide, were observed. The medication, at a dosage of 750 mg/day (250 mg three times daily), has also been found to be equivalent in effectiveness to 250 mg/day oral cyproterone acetate as a monotherapy in the treatment of prostate cancer in a large-scale clinical trial of 310 patients, though its side effect and toxicity profiles (including gynecomastia, diarrhea, nausea, loss of appetite, and liver disturbances) were regarded as considerably worse than those of cyproterone acetate. A dosage of 750 mg/day flutamide (250 mg/three times a day) is roughly equivalent in terms of effectiveness to 50 mg/day bicalutamide when used as the antiandrogen component in combined androgen blockade in the treatment of advanced prostate cancer.
The substrate of this enzyme is geranylgeranyl pyrophosphate, which reacts with three equivalents of reduced nicotinamide adenine dinucleotide phosphate (NADPH), and three protons. The product is phytyl diphosphate and oxidised NADP+. It can also act on geranylgeranyl-chlorophyll a.
Sources: en.wikipedia.org
== V == Lauri Vaska (1925–2015), Estonian/American chemist Louis Nicolas Vauquelin (1763–1829), French pharmacist and chemist, discovered the elements beryllium and chromium Vincent du Vigneaud (1901–1978), 1955 Nobel Prize in Chemistry Artturi Ilmari Virtanen (1895–1973), chemist, Nobel Prize laureate Max Volmer, Germany (1885–1965) Alessandro Volta (1745–1827), Italian electrochemist, invented the voltaic cell Alexander Vinogradov (1895-1975), Soviet geochemist
=== Pharmacokinetics === Bimatoprost is well absorbed through the cornea. It starts lowering intraocular pressure after four hours, lasting for at least 24 hours. A low percentage enters the bloodstream. In the blood plasma, peak concentrations are reached after 10 minutes, then drop below the detection limit of 25 pg/ml after 1.5 hours. The substance does not accumulate in the body. Plasma protein binding is 88%. Bimatoprost is metabolized by oxidation, N-deethylation and glucuronidation, forming a variety of metabolites. Biological half-life was measured to be 45 minutes after intravenous infusion. 67% are eliminated via the kidney, and 25% via the feces.
== History == Studies in the early 1960s showed that administration of α-MSH caused sexual arousal in rats, sparking interest in α-MSH. In the 1980s, scientists at University of Arizona began developing α-MSH and analogs as potential sunless tanning agents. They synthesized and tested several analogs, including peptides they subsequently named melanotan-I and melanotan II. Very early in the process, one of the scientists, Mac Hadley, was conducting self-experiments with melanotan II. He mistakenly injected himself with twice the intended dose and experienced an eight-hour erection, along with nausea and vomiting. To pursue the tanning agent, melanotan-I was licensed by Competitive Technologies, a technology transfer company operating on behalf of University of Arizona, to an Australian startup called Epitan, which changed its name to Clinuvel in 2006. To pursue the sexual dysfunction agent, melanotan II was licensed by Competitive Technologies to Palatin Technologies. Palatin ceased development of melanotan II in 2000, and synthesized, patented, and began to develop bremelanotide, a likely metabolite of melanotan II that differs from melanotan II in that it has a hydroxyl group where melanotan II has an amide. Competitive Technologies sued Palatin for breach of contract and to try to claim ownership of bremelanotide; the parties settled in 2008, with Palatin retaining rights to bremelanotide, returning rights to melanotan II to Competitive Technologies, and paying $800,000.
Sources: en.wikipedia.org
Edward Calvin Kendall (March 8, 1886 – May 4, 1972) was an American biochemist. In 1950, Kendall was awarded the Nobel Prize for Physiology or Medicine along with Swiss chemist Tadeusz Reichstein and Mayo Clinic physician Philip S. Hench, for their work with the hormones of the adrenal glands. Kendall not only researched the adrenal glands, he also isolated thyroxine, a hormone of the thyroid gland and worked with the team that crystallized glutathione and identified its chemical structure. Kendall was a biochemist at the Graduate School of the Mayo Foundation at the time of the Nobel award. He received his education at Columbia University. After retiring from his job with the Mayo Foundation, Kendall joined the faculty at Princeton University, where he remained until his death in 1972. Kendall Elementary School, in Norwalk is named for him.
=== Ribosomal RNA catalyzes peptide bond formation === For years, scientists had worked to identify which protein(s) within the ribosome were responsible for peptidyl transferase function during translation, because the covalent linking of amino acids represents one of the most central chemical reactions in all of biology. Careful biochemical studies showed that extensively-deproteinized large ribosomal subunits could still catalyze peptide bond formation, thereby implying that the sought-after activity might lie within ribosomal RNA rather than ribosomal proteins. Structural biologists, using X-ray crystallography, localized the peptidyl transferase center of the ribosome to a highly-conserved region of the large subunit ribosomal RNA (rRNA) that is located at the place within the ribosome where the amino-acid-bearing ends of tRNA bind, and where no proteins are present. These studies led to the conclusion that the ribosome is a ribozyme. The rRNA sequences that make up the ribosomal active site represent some of the most highly conserved sequences in the biological world. Together, these observations indicate that peptide bond formation catalyzed by RNA was a feature of the last common ancestor of all known forms of life.
=== Suspension of campaign === Sanders announced that he was suspending his campaign on April 8, 2020. He stated that he would remain on the ballot in the remaining states and continue to accumulate delegates with the goal of influencing the Democratic Party's platform. On April 14, Sanders endorsed Biden. Biden responded, "I think that your endorsement means a great deal. It means a great deal to me. I think people are going to be surprised that we are apart on some issues but we're awfully close on a whole bunch of others. I'm going to need you—not just to win the campaign, but to govern."
Sources: en.wikipedia.org
They are usually made from bovine hide, porcine skin, fish skin, or poultry cartilage. The raw collagen is hydrolyzed into shorter peptide chains. Source labeling varies by region and product.
Native collagen is a large triple-helical protein found in connective tissue. Collagen peptides are hydrolyzed fragments that are water-soluble and much smaller. The hydrolysis step changes physical behavior, not the basic amino acid building blocks.
No. Molecular weight distribution, amino acid content, and source material can vary. These differences may affect solubility, taste, and performance in foods or supplements. Standardization practices also differ among suppliers.
Size-exclusion chromatography or gel permeation chromatography separates peptides by size in solution. Results are reported as weight-average or number-average molecular weight, but column choice and calibration standards affect comparability between laboratories.